Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701470 | PMC |
| http://dx.doi.org/10.1002/hep4.2071 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comment on "Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis".
Hum Vaccin Immunother
December 2024
Department for Evidence-based Medicine and Evaluation, University for Continuing Education Krems, Krems, Austria.
Transplant nephropathology: Wherefrom, wherein, and whereto.
Clin Transplant
April 2024
The Selzman Institute of Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, USA.
Renal pathology is a relatively recent entry in nephrology. While diseases of the kidney are old, their study began in the 19th century with the report of Richard Bright of the lesions of end-stage kidney disease. Its easy diagnosis from albuminuria soon elevated Bright's nephritis into a leading cause of death.
View Article and Find Full Text PDFEthical concerns regarding heterologous COVID-19 vaccine administration.
Hum Vaccin Immunother
December 2024
Department of Research Analytics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences Saveetha University India.
Advances in virus-induced flowering in tomato.
J Exp Bot
January 2024
Laboratory of Molecular Biology, Wageningen University and Research, 6708 PB, Wageningen, The Netherlands.
This article comments on: 2024. Virus-induced overexpression of heterologous for efficient speed breeding in tomato. Journal of Experimental Botany , 36–44.
View Article and Find Full Text PDFHeterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron.
Front Immunol
December 2023
Laboratorio VacSal, Instituto de Biotecnología y Biología Molecular (IBBM), Facultad de Ciencias Exactas, Universidad Nacional de La Plata, Centro Científico Tecnológico - Consejo Nacional de Investigaciones Científicas y Técnicas (CCT-CONICET), La Plata, Argentina.
In this study, we evaluated the efficacy of a heterologous three-dose vaccination schedule against the Omicron BA.1 SARS-CoV-2 variant infection using a mouse intranasal challenge model. The vaccination schedules tested in this study consisted of a primary series of 2 doses covered by two commercial vaccines: an mRNA-based vaccine (mRNA1273) or a non-replicative vector-based vaccine (AZD1222/ChAdOx1, hereafter referred to as AZD1222).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!